Clinical Trial Update: Dexamethasone, Flurbiprofen Axetil and Delirium After Lung Cancer Surgery [Phase 4]

View source ↗

Summary

Phase 4 trial update on dexamethasone and flurbiprofen axetil for delirium after lung cancer surgery; the study status is terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Carcinoma Non-small-cell Lung
• Surgery Complications

Drugs mentioned

• DEXAMETHASONE (Dexamethasone)
• Delirium
• Flurbiprofen axetil (Flurbiprofen axetil)

Snippet

Sponsor: Peking University First Hospital | Conditions: Carcinoma, Non-Small-Cell Lung, Surgery--Complications | Phase 4 | Status: TERMINATED